http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_965aefec6e90bd2d344f77a98ce22295
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Israel Vlodavsky Vlodavsky |
| name | Israel Vlodavsky |
| given-name | Israel |
| organization-name | From the Harvard–Massachusetts Institute of Technology Division of Health Sciences and Technology (A.B.B., A.G., M.J., D.S.E., T.S., P.S., E.R.E.), Massachusetts Institute of Technology, Cambridge; Cardiovascular Division (M.J., E.R.E.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and Cancer and Vascular Biology Research Center (E.Z., I.V.), Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. Hadassah-Hebrew University HospitalDepartment of Oncology Jerusalem 91120 Israel From the Faculty of Pharmaceutical Sciences (D.Z., A.W., A.P.-L.C., Y.W., F.W., K.N., N.L., B.R.), and Department of Cellular and Physiological Sciences (M.J.B., J.D.J.), University of British Columbia, Canada; and Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Israel (I.V.). Cancer and Vascular Biology Research Center Rappaport Faculty of Medicine, Technion Haifa Israel From the Department of Urology and the Department of Radiation and Clinical Oncology, Hewbrew University Hadassah Medical School, Jerusalem, Israel Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion, Haifa 3525433, Israel Cancer and Vascular Biology Research Center Rappaport, Faculty of Medicine, Technion, Haifa, Israel Cancer and Vascular Biology Research Center (I.V.), The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Cancer and Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine Technion-Israel Institute of Technology, Haifa, Haifa, Israel. Vlodavsk@mail.huji.ac.il. Cancer and Vascular Biology Research Center Rappaport Faculty of Medicine Technion Haifa Israel Cancer and Vascular Biology Research CenterBruce Rappaport Faculty of Medicine, TechnionHaifaIsrael 3Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Haifa, Israel From the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada (A.P.-L.C., A.W., N.L., D.Z., F.W., B.H., B.R.); and Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel (I.V.). Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa 3525422, Israel Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Haifa, Israel. Vlodavsk@mail.huji.ac.il. From the Department of Developmental Biology and Cancer Research (S.S., E.K.), Hebrew University-Hadassah Medical School, Jerusalem; Department of Obstetrics and Gynecology (S.N.-Y., S.Y.), Hadassah University Hospital-Mount Scopus, Jerusalem; and Cancer and Vascular Biology Research Center (E.Z., I.V.), Rappaport Faculty of Medicine, Technion, Haifa, Israel. Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel, Institute of Technology, Haifa, Haifa, Israel. Cancer and Vascular Biology Research Center, the Bruce, Rappaport Faculty of Medicine, Technion, Haifa, Israel Cancer and Vascular Biology Research CenterThe Bruce Rappaport Faculty of Medicine Technion Haifa Israel 1Department of Obstetrics and Gynecology, University Hospital of Heidelberg, 2Translational Immunology Group, 3Immunomonitoring Group, and Departments of 4Theoretical Bioinformatics and 5Molecular Immunology, German Cancer Research Center, and 6Department of Pathology of the University Hospital of Heidelberg, Heidelberg, Germany; and 7Vascular and Tumor Biology Research Center, Technion, Israel Institute of Technology, Haifa, Israel 4Cancer and Vascular Biology Research Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. Cancer Research Institute, University of California, Medical Center, San Francisco, California 94143 Cancer and Vascular Biology Research CenterBruce Rappaport Faculty of Medicine, TechnionHaifa Israel Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel 1Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, 4Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Haifa, Israel Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Department of Radiation and Clinical Oncology, Hadassah University Hospital , Ein Karem, Jerusalem, Israel Cancer and Vascular Biology Research Center Rappaport Faculty of Medicine Haifa Israel 1Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. From the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada (Y.W., D.Z., A.P.-L.C., A.W., K.N., B.R.); and Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel (I.V.). Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; 1Cancer and Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. 1Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel Authors' Affiliations: 1Department of Pathology, 2Center for Metabolic Bone Disease, and 3Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama; 4G. Ronzoni Institute for Chemical and Biochemical Research, Milan, Italy; 5sigma-tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy; 6sigma-tau Research, Mendrisio, Switzerland; 7National Cancer Institute, Foundation IRCCS, Milan, Italy; and 8Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Institute of Evolution, International Graduate Center of Evolution, University of Haifa, Haifa 31905, Israel; and Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Cancer and Vascular Biology Research CenterThe Bruce Rappaport Faculty of MedicineTechnionIsrael Cancer and Vascular Biology Research Center Rappaport, Faculty of Medicine, Technion, Box 9649, 31096 Haifa, Israel Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Department of Oncology, Hadassah-Hebrew University Hospital (R.A., I.V.), Jerusalem 91120, Israel; Rappaport Faculty of Medicine, Cancer and Vascular Biology Research Center, Technion, Haifa, Israel From the Departments of Thoracic and Cardiovascular Surgery (B.M., G.M., A.E.), Oncology (H.A., H.-Q.M., R.I.-M., I.V.), and Bone Marrow Transplantation (A.N.), Hadassah-Hebrew University Hospital, Jerusalem, Israel. 3Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Haifa, Israel. Vascular and Tumor Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Hadassah-Hebrew University Hospital, Jerusalem, Israel Technion Integrated Cancer Center Rappaport Faculty of Medicine Technion Haifa Israel 3Tumor Biology Research Unit, Department of Oncology, Hadassah University Medical Center, Jerusalem, Israel Cancer and Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine Technion Haifa Israel From the Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, and the Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. §Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine, Technion, Haifa, Israel; and the Departments of Bone Marrow Transplantation (A.N.) and Oncology (H.-Q.M., H.E., I.V.), Hadassah-Hebrew University Hospital, Jerusalem, and the Institute of Animal Science (M.P., O.G.), Agricultural Research Organization, the Volcani Center, Bet Dagan, Israel. Department of Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine, Technion, Haifa, Israel Technion Integrated Cancer Center, Technion Rappaport Faculty of Medicine Haifa Israel Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion − Israel Institute of Technology, Haifa 3525422, Israel Cancer and Vascular Biology Research Center; Rappaport Faculty of Medicine; Technion 9649, 31096 Haifa Israel Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; and Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa; and Faculty of Medicine Cancer and Vascular Biology Research Center Rappaport Technion Haifa Israel Department of Oncology, Hadassah University Hospital, Jerusalem, Israel and the Max-Planck Institut für Biochemie, Martinsried, Germany Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion-Israel, Institute of Technology, Haifa, Israel 1Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel and ‡Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Israel; Laboratories for The University of Alabama at Birmingham, Birmingham, Alabama, and Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel Technion Integrated Cancer Center Rappaport Faculty of Medicine Technion Israel The Rappaport Faculty of Medicine and Research Institute; Technion-Israel Institute of Technology; Haifa 31096; Israel Department of Medicinal Chemistry, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel, and Department of Oncology, Hadassah University Hospital, Jerusalem 91120, Israel Departments of Oncology, Nuclear Medicine, and Medicine, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel; Department of Cellular Immunology, German Cancer Research Center, D69120 Heidelberg, Germany; Department of Cell and Animal Biology, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel; and Vascular Biology Research Center, Rappaport Family Research Institute and the Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden; Department of Public Health and Caring Science, Division of Molecular Geriatrics, Rudbeck Laboratory, Uppsala University, Box 609, SE-751 25 Uppsala, Sweden; Departments of Oncology and Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel; Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096,... Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; and From the Department of Urology, the Department of Cancer Research and the Department of Radiation and Clinical Oncology, Hebrew University-Hadassah Medical School, Jerusalem, Israel Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. Cancer and Vascular Biology Research Center; the Bruce Rappaport Faculty of Medicine; Technion; Haifa, Israel Hadassah‐Hebrew University Hospital Jerusalem Israel Technion Integrated Cancer Center (TICC), Rappaport, Faculty of Medicine, Technion, Haifa 31096, Israel Cancer and Vascular Biology Research Center; The Rappaport Faculty of Medicine; Technion; Haifa Israel Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine, Technion, Haifa, Israel Department of OncologyHadassah-Hebrew University HospitalJerusalem91120 Cancer and Vascular Biology Research Center Bruce Rappaport Faculty of Medicine, Technion Haifa Israel Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; Department of Oncology, Hadassah University Hospital, Jerusalem, Israel. Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel. Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine , Technion, Haifa, Israel From the Department of Cardiology (M.B., A.S., S.P., A.E., H.H., D.A.) and Pathology Rambam Health Care Campus, Haifa, Israel; Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine and Research Institute, Technion, Haifa (E.S.), Israel (A.G., G.A., I.S., V.C.-K., E.A., N.I., I.V.); and Institute of Dental Science, Hadassah Faculty of Dental Medicine, Hebrew University, Jerusalem, Israel (S.A.-P., G.N.). ‡Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Internal Medicine, Haifa, Israel Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Department of Genetics, Weizmann Institute of Science, Rehovot, Israel The Rappaport Faculty of Medicine Technion Integrated Cancer Center (TICC) Haifa Israel Cancer and Vascular Biology Research CenterThe Bruce Rappaport Faculty of MedicineTechnionHaifaIsrael |
Incoming Links
Total number of triples: 460.